T 0596/20 of 23.10.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T059620.20231023
- Date of decision
- 23 October 2023
- Case number
- T 0596/20
- Online on
- 6 December 2023
- Petition for review of
- -
- Application number
- 13709190.6
- IPC class
- C07K 14/75
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- IMPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY
- Applicant name
- Octapharma AG
- Opponent name
- Strawman Limited
Biotest AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Inventive step - (no)
Amendments - extension beyond the content of the application as filed (yes)
Auxiliary requests 5 to 10 - not admitted - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.